Literature DB >> 14534913

Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.

Jau-Shin Lou1, Greg Kearns, Theodore Benice, Barry Oken, Gary Sexton, John Nutt.   

Abstract

We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double-blind, placebo-controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty-five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50% of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60% of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534913     DOI: 10.1002/mds.10505

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  42 in total

Review 1.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

2.  Neuroimaging and clinical predictors of fatigue in Parkinson disease.

Authors:  Kelvin L Chou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2015-12-02       Impact factor: 4.891

3.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

Review 4.  Vigilance, alertness, or sustained attention: physiological basis and measurement.

Authors:  B S Oken; M C Salinsky; S M Elsas
Journal:  Clin Neurophysiol       Date:  2006-04-03       Impact factor: 3.708

5.  Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.

Authors:  Thomas Müller; Siegfried Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2008-03-12       Impact factor: 3.575

6.  Fatigue in levodopa-naive subjects with Parkinson disease.

Authors:  G Schifitto; J H Friedman; D Oakes; L Shulman; C L Comella; K Marek; S Fahn
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

7.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

8.  Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.

Authors:  Matej Skorvanek; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Radka Ghorbani Saeedian; Johan W Groothoff; Zuzana Gdovinova; Jitse P van Dijk
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

Review 9.  Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy.

Authors:  Benzi M Kluger; Lauren B Krupp; Roger M Enoka
Journal:  Neurology       Date:  2013-01-22       Impact factor: 9.910

Review 10.  Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment.

Authors:  Jau-Shin Lou
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.